Please use this identifier to cite or link to this item:
http://dspace.hmtu.edu.vn/handle/DHKTYTHD_123/240Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ghielmini, Michele | - |
| dc.date.accessioned | 2015-11-20T07:17:37Z | - |
| dc.date.available | 2015-11-20T07:17:37Z | - |
| dc.date.issued | 2005 | - |
| dc.identifier.uri | http://220.231.117.85:8000/handle/DHKTYTHD_123/240 | - |
| dc.language.iso | en | vi |
| dc.publisher | American Society of Hematology | vi |
| dc.subject | Huyết học | vi |
| dc.title | Multimodality Therapies and Optimal Schedule of Antibodies: Rituximab in Lymphoma as an Example | vi |
| Appears in Collections | Huyết học = Hematology | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Hematology-2005-Ghielmini-321-8.pdf Restricted Access | 103.82 kB | Adobe PDF |  Request Item |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.